Our findings demonstrate that the combination of Prop+αCD40 effectively modulates the tumor microenvironment, leading to a pronounced increase in CD8+ T cell and cytotoxic T cell infiltration, and a reduction in Tregs compared to tumors treated with monotherapies or untreated control. This evidence concerns the gene CD8A and neoplasm.